Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study

• Published in: Medicine (Baltimore) Vol. 102; no. 5; p. e32866
• Main Authors: Paksoy, Nail, Khanmammadov, Nijat, Doğan, İzzet, Ferhatoğlu, Ferhat, Ahmed, Melin Aydan, Karaman, Sule, Aydiner, Adnan
• Format: Journal Article
• Language: English
• Published: United States Lippincott Williams & Wilkins 03.02.2023
• Subjects: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cross-Sectional Studies; Humans; Male; Middle Aged; Observational Study; Paclitaxel - therapeutic use; Retrospective Studies; Sarcoma, Kaposi - complications; Skin Neoplasms - drug therapy

Kaposi sarcoma is an angioproliferative disease associated with human herpes virus 8 infection. Classic Kaposi sarcoma (CKS) usually develops in older age. Although CKS often does not require systemic therapy, systemic therapy can be administered in progressively symptomatic patients. In this real-l...